Cargando…
Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
OBJECTIVE: To evaluate the clinical utility of individualising dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in an all-comers population, including ST-elevation myocardial infarction (STEMI) patients. SETTING: Tertiary care single centre registry. PARTICIPANTS: 1008...
Autores principales: | Christ, Günter, Siller-Matula, Jolanta M, Francesconi, Marcel, Dechant, Cornelia, Grohs, Katharina, Podczeck-Schweighofer, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216867/ https://www.ncbi.nlm.nih.gov/pubmed/25361837 http://dx.doi.org/10.1136/bmjopen-2014-005781 |
Ejemplares similares
-
Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008) -
Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy
por: Dechant, Cornelia, et al.
Publicado: (2012) -
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
por: Ostrowska, Małgorzata, et al.
Publicado: (2019) -
Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
por: Mezier, A., et al.
Publicado: (2023) -
Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry
por: Siriyotha, Sukanya, et al.
Publicado: (2023)